Edwards Lifesciences Corp (EW)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 77.11% | 77.94% | 79.13% | 79.99% | 80.23% | 78.95% | 77.94% | 76.76% | 76.33% | 75.77% | 75.53% | 75.17% | 75.24% | 75.37% | 74.81% | 74.24% | 74.25% | 74.27% | 74.82% | 75.43% |
| Operating profit margin | 25.58% | 27.16% | 27.70% | 30.94% | 32.61% | 31.25% | 31.12% | 32.66% | 32.39% | 32.74% | 33.19% | 20.62% | 20.43% | 19.58% | 18.32% | 27.39% | 26.33% | 19.97% | 19.79% | 20.14% |
| Pretax margin | 26.70% | 28.14% | 28.40% | 31.52% | 32.96% | 31.42% | 31.21% | 32.72% | 32.61% | 44.53% | 45.50% | 34.12% | 34.20% | 33.91% | 32.82% | 41.41% | 40.74% | 42.44% | 43.15% | 44.26% |
| Net profit margin | 23.38% | 24.57% | 24.58% | 27.13% | 28.38% | 27.21% | 27.24% | 28.79% | 28.80% | 40.51% | 41.59% | 32.09% | 32.08% | 32.04% | 31.20% | 38.18% | 37.99% | 40.63% | 41.35% | 43.98% |
The profitability ratios of Edwards Lifesciences Corp exhibit consistent performance over the past eight quarters. The gross profit margin has remained relatively stable, ranging from 76.58% to 79.93%, indicating the company's ability to maintain a high level of profitability after accounting for the cost of goods sold.
The operating profit margin, which measures the company's profitability from core operations, has shown a similar trend, with values ranging from 30.03% to 33.22%. This indicates that Edwards Lifesciences has effectively managed its operating expenses to generate profits.
The pretax margin, reflecting the company's profitability before taxes, demonstrates a stable performance, with values oscillating between 26.61% and 32.84%. This suggests that the company has been efficient in managing its tax liabilities and operating expenses.
Lastly, the net profit margin, which reveals the company's profitability after all expenses, including taxes, has ranged from 23.35% to 28.72%. This metric highlights the company's ability to generate bottom-line profits from its operations consistently.
Overall, Edwards Lifesciences Corp has demonstrated solid profitability performance over the analyzed quarters, showcasing efficiency in managing costs and generating profits across different levels of the income statement.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 16.38% | 16.88% | 17.39% | 19.63% | 21.09% | 19.39% | 19.74% | 20.73% | 19.88% | 20.43% | 21.34% | 12.80% | 12.40% | 12.60% | 12.35% | 20.25% | 17.68% | 13.92% | 14.09% | 14.08% |
| Return on assets (ROA) | 14.98% | 15.27% | 15.43% | 17.21% | 18.35% | 16.89% | 17.27% | 18.27% | 17.68% | 25.28% | 26.73% | 19.92% | 19.47% | 20.61% | 21.03% | 28.23% | 25.50% | 28.32% | 29.44% | 30.74% |
| Return on total capital | 21.17% | 21.80% | 22.46% | 25.83% | 27.31% | 24.58% | 25.43% | 27.10% | 26.28% | 27.17% | 28.54% | 17.57% | 17.36% | 17.83% | 17.90% | 27.38% | 24.18% | 18.84% | 19.18% | 19.05% |
| Return on equity (ROE) | 21.09% | 21.49% | 21.79% | 24.90% | 26.21% | 23.46% | 24.49% | 26.32% | 25.76% | 37.23% | 39.90% | 30.85% | 30.81% | 33.29% | 35.20% | 43.97% | 39.89% | 44.29% | 46.88% | 48.77% |
Based on the provided data, Edwards Lifesciences Corp demonstrates strong profitability ratios across different periods.
1. Operating Return on Assets (Operating ROA):
- The company's Operating ROA fluctuated between 18.45% to 20.55% over the last eight quarters, indicating efficient utilization of assets to generate operating income.
2. Return on Assets (ROA):
- ROA ranged from 14.98% to 17.21% during the same period, signifying the company's ability to generate profits from its total assets.
3. Return on Total Capital:
- Edwards Lifesciences Corp's Return on Total Capital varied between 23.84% to 27.04%, showing the effectiveness of the company in generating returns for both equity and debt capital providers.
4. Return on Equity (ROE):
- The ROE ranged from 21.09% to 24.90% over the last eight quarters, highlighting the company's capability in generating profits for the shareholders.
Overall, Edwards Lifesciences Corp's profitability ratios indicate consistent and strong performance in utilizing its assets and capital to generate income and returns for its stakeholders.
See also:
Edwards Lifesciences Corp Profitability Ratios (Quarterly Data)